Scott Akamine has sold CERE and made no open-market buys since Dec 2023

Scott M. Akamine is a biopharmaceutical legal executive and corporate insider who served as Chief Legal Officer and Corporate Secretary of Cerevel Therapeutics Holdings, Inc. (CERE), where he oversaw the company’s legal affairs during a period that included its acquisition by AbbVie in 2024.( Prior to joining Cerevel in 2021, he was general counsel and corporate secretary at AEON Biopharma, Inc., managing legal and key administrative functions such as business development, corporate governance, intellectual property, and compliance.( At Cerevel, his role as chief legal officer and secretary placed him at the center of corporate governance and securities matters, including insider transactions reported on Form 4 filings for CERE.(

Akamine’s career includes senior legal roles at CoreLogic, Inc. (associate general counsel and interim general counsel) and Incipio, LLC (general counsel and corporate secretary), as well as progressively responsible in‑house positions at Allergan, Inc. until its acquisition by Actavis plc.( He began his legal career as a corporate attorney at Latham & Watkins.( Akamine holds a Bachelor of Arts from Chapman University and a Juris Doctor from Pepperdine University School of Law, where he graduated with honors.( Following his tenure at Cerevel, he was appointed Chief Legal Officer of Kailera Therapeutics, continuing his focus on guiding healthcare and biopharmaceutical companies through complex regulatory and transactional environments.(

Written by Perplexity from public sources.